This page has been fact checked by an experienced mesothelioma Patient Advocate. Sources of information are listed at the bottom of the article.
We make every attempt to keep our information accurate and up-to-date.
Please Contact Us with any questions or comments.
Dr. Farid Gharagozloo is a board-certified thoracic and cardiothoracic surgeon and leading expert in robotic thoracic surgery whose specialties include minimally invasive surgery for the treatment of malignant mesothelioma. His career is distinguished by having been the first in the world to perform robot-assisted extrapleural pneumonectomies. He is dedicated to using robotics to perform better and safer oncologic operations which reduce blood loss, shorten hospital stays, and lower the risk of infection and death. In addition to his role as Surgeon-in-Chief of the Institute for Advanced Thoracic Surgery, Dr. Gharagozloo is Professor of Surgery at the University of Central Florida.
Education and Career
Dr. Gharagozloo began his education at Johns Hopkins University, where he earned his undergraduate degree followed by his medical degree at Johns Hopkins School of Medicine. He completed his internship and residency in Surgery at the Mayo Graduate School of Medicine in Rochester, Minnesota, and also pursued a fellowship in Cardiac Surgery Research at Brigham & Women’s Hospital, Harvard Medical School.
Dr. Gharagozloo has had a distinguished career, serving as Professor and Chief of Cardiothoracic Surgery at George Washington University Medical Center and as Professor and Surgeon-in-Chief of that facility’s Washington Institute of Thoracic and Cardiovascular Surgery; as Professor and Chief of Thoracic Surgery at University of Arizona Medical Center, where he performed the world’s first and second robot-assisted extrapleural pneumonectomy for the treatment of malignant mesothelioma; as Surgeon-in-Chief and Professor of Surgery at the Center for Advanced Thoracic and Esophageal Surgery at Florida Hospital Celebration Health and University of Central Florida; and now as Professor of Surgery at the University of Central Florida and Surgeon-in-Chief of the Institute for Advanced Thoracic Surgery. He also served as the Director of Cardiothoracic Surgery at the Global Robotics Institute.
Dr. Gharagozloo is the Senior Editor of the Textbook of Robotic Surgery, which was published in 2021. He is also the author of 234 peer-reviewed publications and 35 book chapters. He holds U.S. and European patents for a revolutionary tissue healing accelerant.
Research Interests, Memberships, and Honors
Dr. Gharagozloo’s research interests include minimally invasive robotic thoracic surgery, surgery for benign and malignant esophageal disorders, and surgery for advanced thoracic malignancies including malignant pleural mesothelioma.
His memberships and honors include:
- Director, International Society of Minimally Invasive Cardiothoracic Surgery, 2018-2022
- President Society of Robotic Surgery, 2017-2022
- Fellow of the American College of Healthcare Executives
- Executive Board, Clinical Robotic Surgery Association
- Member of the Board and Secretary, Society of Robotic Surgery
- U.S. News and World Report America’s Top Doctors
Dr. Ghargozloo’s pioneering work as a thoracic surgeon has changed the face of minimally invasive procedures for the treatment of malignant pleural mesothelioma.Get Your FREE Mesothelioma Packet
Written by Terri Oppenheimer
Terri Oppenheimer has been writing about mesothelioma and asbestos topics for over ten years. She has a degree in English from the College of William and Mary. Terri’s experience as the head writer of our Mesothelioma.net news blog gives her a wealth of knowledge which she brings to all Mesothelioma.net articles she authors.
Page Edited by Patient Advocate Dave Foster
Dave has been a mesothelioma Patient Advocate for over 10 years. He consistently attends all major national and international mesothelioma meetings. In doing so, he is able to stay on top of the latest treatments, clinical trials, and research results. He also personally meets with mesothelioma patients and their families and connects them with the best medical specialists and legal representatives available.